+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Acquired Hemophilia Drugs Market 2021-2027

  • PDF Icon

    Report

  • 140 Pages
  • January 2022
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5559543
Global Acquired Hemophilia Drugs Market Size, Share & Trends Analysis Report, By Type (Hemophilia A, Hemophilia B, and Hemophilia C), By Treatment (On-Demand and Prophylaxis), By Therapy (Replacement Therapy, ITI Therapy, and Gene Therapy), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) Forecast (2021-2027)

The global acquired hemophilia drugs market is anticipated to grow at a considerable CAGR during the forecast period. The major factors driving the growth of the market include the rising burden of rare disorder among population globally, increasing awareness of hemophilia, and government contribution towards prevention and control of such disease. Moreover, significant investment by key pharmaceutical companies in R&D of novel therapies for hemophilia is also propelling the expansion of market growth.

The global acquired hemophilia drugs market is segmented based on type, treatment, therapy, and distribution channel. Based on type, the market is sub-segmented into hemophilia A, hemophilia B, and hemophilia C. On the basis of treatment, the market is sub-segmented into on-demand and prophylaxis. Based on therapy, the market is sub-categorized into replacement therapy, ITI therapy, and gene therapy. On the basis of distribution channel, the market is sub-segmented into hospital pharmacy, online pharmacy, and retail pharmacy.

Geographically, the global acquired hemophilia drugs market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.

Some of the companies operating in the global acquired hemophilia drugs market include Shire (Baxalta); CSL Behring; Pfizer, Inc.; Bayer AG; BioMarin, Spark Therapeutics, Inc.; Genzyme Corp., and others.

Market Segmentation


  • Global Acquired Hemophilia Drugs Market Research and Analysis by Type
  • Global Acquired Hemophilia Drugs Market Research and Analysis by Treatment
  • Global Acquired Hemophilia Drugs Market Research and Analysis by Therapy
  • Global Acquired Hemophilia Drugs Market Research and Analysis by Distribution channel

The Report Covers


  • Comprehensive research methodology of the global acquired hemophilia drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global acquired hemophilia drugs market.
  • Insights about market determinants that are stimulating the global acquired hemophilia Drugs market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. Global Acquired Hemophilia Drugs Market by Type
4.1.1. Hemophilia A
4.1.2. Hemophilia B
4.1.3. Hemophilia C
4.2. Global Acquired Hemophilia Drugs Market by Treatment
4.2.1. On-Demand
4.2.2. Prophylaxis
4.3. Global Acquired Hemophilia Drugs Market by Therapy
4.3.1. Replacement Therapy
4.3.2. ITI Therapy
4.3.3. Gene Therapy
4.4. Global Acquired Hemophilia Drugs Market by Distribution Channel
4.4.1. Hospital Pharmacy
4.4.2. Online Pharmacy
4.4.3. Retail Pharmacy
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Aptevo Therapeutics
6.2. Bayer AG
6.3. CSL Behring
6.4. Genzyme Corp.
6.5. Grifols SA
6.6. F. Hoffman La Roche Ltd.
6.7. Octapharma AG
6.8. Pfizer Inc
6.9. Spark Therapeutics, Inc
6.10. Takeda Pharmaceutical Co. Ltd.
List of Tables
1. Global Acquired Hemophilia Drugs Market Research and Analysis by Type, 2020-2027 ($ Million)
2. Global Hemophilia a Acquired Hemophilia Drugs Market Research and Analysis by Region, 2020-2027 ($ Million)
3. Global Hemophilia B Acquired Hemophilia Drugs Market Research and Analysis by Region, 2020-2027 ($ Million)
4. Global Hemophilia C Acquired Hemophilia Drugs Market Research and Analysis by Region, 2020-2027 ($ Million)
5. Global Acquired Hemophilia Drugs Market Research and Analysis by Treatment, 2020-2027 ($ Million)
6. Global On-Demand Acquired Hemophilia Drugs Market Research and Analysis by Region, 2020-2027 ($ Million)
7. Global Prophylaxis Acquired Hemophilia Drugs Market Research and Analysis by Region, 2020-2027 ($ Million)
8. Global Acquired Hemophilia Drugs Market Research and Analysis by Therapy, 2020-2027 ($ Million)
9. Global Acquired Hemophilia Drugs for Replacement Therapy Market Research and Analysis by Region, 2020-2027 ($ Million)
10. Global Acquired Hemophilia Drugs for Iti Therapy Market Research and Analysis by Region, 2020-2027 ($ Million)
11. Global Acquired Hemophilia Drugs for Gene Therapy Market Research and Analysis by Region, 2020-2027 ($ Million)
12. Global Acquired Hemophilia Drugs Market Research and Analysis by Distribution Channel, 2020-2027 ($ Million)
13. Global Acquired Hemophilia Drugs in Hospital Pharmacy Market Research and Analysis by Region, 2020-2027 ($ Million)
14. Global Acquired Hemophilia Drugs in Online Pharmacy Market Research and Analysis by Region, 2020-2027 ($ Million)
15. Global Acquired Hemophilia Drugs in Retail Pharmacy Market Research and Analysis by Region, 2020-2027 ($ Million)
16. North American Acquired Hemophilia Drugs Market Research and Analysis by Country, 2020-2027 ($ Million)
17. North American Acquired Hemophilia Drugs Market Research and Analysis by Type, 2020-2027 ($ Million)
18. North American Acquired Hemophilia Drugs Market Research and Analysis by Treatment, 2020-2027 ($ Million)
19. North American Acquired Hemophilia Drugs Market Research and Analysis Bytherapy, 2020-2027 ($ Million)
20. North American Acquired Hemophilia Drugs Market Research and Analysis Bydistribution Channel, 2020-2027 ($ Million)
21. European Acquired Hemophilia Drugs Market Research and Analysis by Country, 2020-2027 ($ Million)
22. European Acquired Hemophilia Drugs Market Research and Analysis by Type, 2020-2027 ($ Million)
23. European Acquired Hemophilia Drugs Market Research and Analysis by Treatment, 2020-2027 ($ Million)
24. European Acquired Hemophilia Drugs Market Research and Analysis by Therapy, 2020-2027 ($ Million)
25. European Acquired Hemophilia Drugs Market Research and Analysis by Distribution Channel, 2020-2027 ($ Million)
26. Asia-Pacific Acquired Hemophilia Drugs Market Research and Analysis by Country, 2020-2027 ($ Million)
27. Asia-Pacific Acquired Hemophilia Drugs Market Research and Analysis by Type, 2020-2027 ($ Million)
28. Asia-Pacific Acquired Hemophilia Drugs Market Research and Analysis by Therapy, 2020-2027 ($ Million)
29. Asia-Pacific Acquired Hemophilia Drugs Market Research and Analysis by Treatment, 2020-2027 ($ Million)
30. Asia-Pacific Acquired Hemophilia Drugs Market Research and Analysis by Distribution Channel, 2020-2027 ($ Million)
31. Rest of the World Acquired Hemophilia Drugs Market Research and Analysis by Type, 2020-2027 ($ Million)
32. Rest of the World Acquired Hemophilia Drugs Market Research and Analysis by Treatment, 2020-2027 ($ Million)
33. Rest of the World Acquired Hemophilia Drugs Market Research and Analysis by Therapy, 2020-2027 ($ Million)
34. Rest of the World Acquired Hemophilia Drugs Market Research and Analysis by Distribution Channel, 2020-2027 ($ Million)
List of Figures
1. Global Acquired Hemophilia Drugs Market Share by Type, 2020 Vs 2027 (%)
2. Global Acquired Hemophilia Drugs Market Share Bytreatment, 2020 Vs 2027 (%)
3. Global Acquired Hemophilia Drugs Market Share Bytherapy, 2020 Vs 2027 (%)
4. Global Acquired Hemophilia Drugs Market Share Bydistribution Channel, 2020 Vs 2027 (%)
5. Global Acquired Hemophilia Drugs Market Share by Geography, 2020 Vs 2027 (%)
6. Us Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
7. Canada Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
8. UK Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
9. France Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
10. Germany Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
11. Italy Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
12. Spain Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
13. Rest of Europe Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
14. India Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
15. China Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
16. Japan Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
17. Rest of Asia-Pacific Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)
18. Rest of the World Acquired Hemophilia Drugs Market Size, 2020-2027 ($ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Aptevo Therapeutics
  • Bayer AG
  • CSL Behring
  • Genzyme Corp.
  • Grifols SA
  • F. Hoffman La Roche Ltd.
  • Octapharma AG
  • Pfizer Inc
  • Spark Therapeutics, Inc.
  • Takeda Pharmaceutical Co. Ltd.